Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Facebook
Tweet
Print
Anna Tena
Sr. International Market Access Manager
AOP Health, Austria
Poster(s):
(4-024) Cost-Effectiveness Analysis of Landiolol, an Ultra-short-acting Beta-antagonist, for Treatment of Sepsis/SIRS-related Supraventricular Tachycardia in the ICU: US Perspective
Monday, December 8, 2025
2:00 PM - 3:30 PM
(8-093) Budget Impact Analysis of Landiolol, an Ultra-short-acting Beta-antagonist, for the Treatment of Sepsis/SIRS-related Supraventricular Tachycardia in the ICU: US Perspective
Tuesday, December 9, 2025
2:00 PM - 3:30 PM
